Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

about

Strategies for designing synthetic immune agonists.Investigational new drugs for allergic rhinitis.First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated.

P2860

Q38841677-FC2C2224-0543-4990-B8DD-94646F62B0F7 Q39111947-F5B2D4BA-7ECF-4E88-8CC0-ECC0DC398D6C Q46090169-200DF0BA-C4B8-421C-8C68-8E781922E752

P2860

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

Item

http://www.wikidata.org/entity/Q36625355

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@ast

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@en

type

Item

label

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@ast

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@en

prefLabel

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@ast

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@en

P1476

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

@en

P2093

Ajay Aggarwal

http://www.w3.org/2001/XMLSchema#string

David Keeling

http://www.w3.org/2001/XMLSchema#string

John Bell

http://www.w3.org/2001/XMLSchema#string

Justine Maltby

http://www.w3.org/2001/XMLSchema#string

Maarten Kraan

http://www.w3.org/2001/XMLSchema#string

Mark Biffen

http://www.w3.org/2001/XMLSchema#string

Sara Asimus

http://www.w3.org/2001/XMLSchema#string

Stephen Delaney

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: Type I IFN reverses human Th2 commitment and stability by suppressing GATA3

Toll-like receptors

Environmental exposure to endotoxin and its relation to asthma in school-age children

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Allergic diseases and asthma: a global public health concern and a call to action.

Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies.

Regulation of adaptive immunity by the innate immune system

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.

Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity

P304

e000113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJRESP-2015-000113

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295832822

http://www.w3.org/2001/XMLSchema#string

P698

26933507

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4769423

http://www.w3.org/2001/XMLSchema#string

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

about

P2860

P2860

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932